ADC Biotechnology

ADC Biotechnology (ADC Bio) is an innovative biotechnology company. It specialises in developing new process technologies for antibody drug conjugates (ADCs) which help speed up, simplify and lower the production costs of the latest generation of anticancer blockbuster ADC drugs.
ADC Bio’s proprietary Lock-Release technology is the only commercially available system that controls aggregation at source, is scaleable, ensures consistency of quality and purity, and is capable of meeting GMP regulatory requirements required to produce materials for use in human clinical trials.